| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 213.586 | 132.276 | 138.837 | 179.183 | 189.636 | 160.393 | 214.930 | 224.385 | 240.795 | 284.309 |
| Total Income - EUR | 247.555 | 163.307 | 140.775 | 179.183 | 189.649 | 163.424 | 215.174 | 224.388 | 240.800 | 284.311 |
| Total Expenses - EUR | 289.477 | 159.562 | 165.017 | 163.956 | 171.036 | 162.026 | 188.184 | 203.189 | 231.716 | 257.781 |
| Gross Profit/Loss - EUR | -41.921 | 3.745 | -24.243 | 15.228 | 18.613 | 1.398 | 26.991 | 21.199 | 9.084 | 26.530 |
| Net Profit/Loss - EUR | -41.921 | 3.745 | -25.527 | 13.436 | 16.717 | -90 | 24.882 | 19.000 | 6.965 | 22.904 |
| Employees | 26 | 18 | 16 | 15 | 14 | 12 | 11 | 13 | 14 | 13 |
Check the financial reports for the company - Neurorad Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.530 | 7.495 | 4.447 | 1.095 | 4.126 | 3.486 | 3.673 | 5.407 | 4.501 | 3.598 |
| Current Assets | 246.470 | 218.474 | 34.745 | 44.539 | 56.923 | 58.708 | 81.873 | 100.160 | 51.677 | 64.640 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 1.251 | 0 | 0 | 0 |
| Receivables | 221.138 | 199.717 | 29.972 | 34.016 | 51.053 | 45.313 | 48.458 | 69.512 | 30.694 | 25.802 |
| Cash | 25.332 | 18.757 | 4.774 | 10.523 | 5.870 | 13.395 | 32.165 | 30.648 | 20.984 | 38.838 |
| Shareholders Funds | 6.072 | 9.756 | -15.937 | -2.209 | 14.698 | 14.330 | 38.895 | 15.074 | 21.993 | 44.774 |
| Social Capital | 135 | 134 | 131 | 129 | 126 | 124 | 121 | 122 | 121 | 121 |
| Debts | 38.888 | 216.214 | 55.129 | 47.843 | 46.351 | 47.863 | 46.652 | 90.561 | 34.220 | 23.467 |
| Income in Advance | 212.040 | 179.151 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neurorad Srl